The North American Society for Pediatric and Adolescent Gynecology (NASPAG) has provided guidance for diagnosing and managing vulvar lichen sclerosus in pediatric patients. The North American Society ...
A CDC report shows only 23% of U.S. teens get enough sleep, with disparities highlighting the need for targeted health interventions. The findings regarding sleep behaviors highlight a trend of ...
Digital tools like health apps, texts, and telemedicine show promise in managing childhood obesity, but require sustained engagement for long-term impact. A review article published in Frontiers aimed ...
Dr Dawson is chief of Adolescent Medicine Services, Carl R Darnall Army Medical Center Pediatric Clinic, Fort Hood, Texas.
The latest scientific statement from the American Heart Association takes aim at offering clinicians with a summary of contemporary evidence related to the prevalence and increase in long-term risk ...
Long-acting injectable HIV treatment given every 2 months was safe, well tolerated, and strongly preferred by adolescents in a recent study. Maternal influenza and TDaP vaccination during pregnancy ...
According to the FDA, infant monitors sold without agency authorization pose safety risks and are not approved to prevent SIDS or SUID. The FDA issued a safety communication warning consumers, ...
FDA accepts MannKind’s sBLA for Afrezza in children and adolescents with diabetes. The FDA has accepted MannKind Corporation’s sBLA to expand the indication of Afrezza (insulin human) Inhalation ...
Their smaller size, higher metabolic rate, and greater body water percentage mean they lose fluids more quickly. Proper hydration is a foundational—but often underemphasized—aspect of pediatric ...
Here: a "how to" on Gomco circumcision, the method most commonly used in the US. Although circumcision is commonly thought to have originated with Abraham (the patriarch of the Israelites) some 4000 ...
The expanded indication is approved to reduce excess body weight and maintain reduction long-term in children 2 years and up with obesity due to BBS, POMC, or LEPR deficiency. The FDA has approved an ...
Berotralstat becomes the first targeted oral prophylactic therapy for patients with HAE 2 years or older. The rare, inherited disease is characterized by unpredictable, potentially life-threatening ...